Evome Medical Technologies, Inc. Accretion Expense
Evome Medical Technologies, Inc. reported Accretion Expense of CAD 1.44 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2023-11-14
- Evome Medical Technologies, Inc. accretion expense for the quarter ending 2023-09-30 was 1.16M CAD, a 527.51% increase year-over-year.
- Evome Medical Technologies, Inc. accretion expense for the quarter ending 2023-06-30 was 172.15K CAD, a 176.54% increase year-over-year.
- Evome Medical Technologies, Inc. accretion expense for the quarter ending 2023-03-31 was 104.66K CAD, a 86.08% increase year-over-year.
- Evome Medical Technologies, Inc. accretion expense for the quarter ending 2022-11-30 was 97.70K CAD, a 0.92% decline year-over-year.
- Evome Medical Technologies, Inc. accretion expense for fiscal 2022 was 202.84K CAD.
- Evome Medical Technologies, Inc. accretion expense for fiscal 2021 was 0.00 CAD.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 10 month | Accretion Expense 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | 1.16M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 1.34M CAD derived: sum of 2 quarters · filed 2023-11-14 | 1.44M CAD 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 172.15K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 276.81K CAD 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 104.66K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 248.13K CAD 10-KT · filed 2023-04-03 | ||||
| 2022-11-30 | 97.70K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17 | 221.78K CAD 10-Q · filed 2023-01-17 | |||
| 2022-09-30 | 185.53K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 304.03K CAD 10-Q · filed 2023-11-14 | |||
| 2022-08-31 | 62.50K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17 | 124.08K CAD 10-Q · filed 2022-10-17 | |||
| 2022-06-30 | 62.25K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 118.50K CAD 10-Q · filed 2023-08-14 | |||
| 2022-05-31 | 61.58K CAD 10-Q · filed 2022-07-15 | ||||
| 2022-03-31 | 56.25K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-02-28 | 56.41K CAD derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03 | 155.03K CAD derived: sum of 2 quarters · filed 2023-04-03 | 196.41K CAD derived: sum of 3 quarters · filed 2023-04-03 | 202.84K CAD 10-KT · filed 2023-04-03 | |
| 2021-12-31 | 114.60K CAD 10-KT · filed 2023-04-03 | ||||
| 2021-11-30 | 98.61K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17 | 140.00K CAD derived: sum of 2 quarters · filed 2023-01-17 | 146.43K CAD 10-Q · filed 2023-01-17 | 146.43K CAD derived: sum of 4 quarters · filed 2023-01-17 | |
| 2021-08-31 | 41.39K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17 | 47.82K CAD 10-Q · filed 2022-10-17 | 47.82K CAD derived: sum of 3 quarters · filed 2022-10-17 | 47.82K CAD derived: sum of 4 quarters · filed 2022-10-17 | |
| 2021-05-31 | 6.43K CAD 10-Q · filed 2022-07-15 | 6.43K CAD derived: sum of 2 quarters · filed 2022-07-15 | 6.43K CAD derived: sum of 3 quarters · filed 2022-07-15 | ||
| 2021-02-28 | 0.00 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | 0.00 CAD derived: sum of 2 quarters · filed 2022-05-31 | 0.00 CAD 10-K · filed 2022-05-31 | ||
| 2020-11-30 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-14 | 0.00 CAD 10-Q · filed 2022-01-14 | |||
| 2020-08-31 | 0.00 CAD 10-Q · filed 2021-10-15 |